Floatz logo

Alphanate Sd/Ht

Severe Hemophilia A

Grifols Biologicals, LLCPhase 4 / ApprovedDormant
BB
68/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
54/ 100
Competitive Position
89/ 100

Competitive context

10 Active assets in the Severe Hemophilia A cohort.

Asset / SponsorPhaseRating
HUMAN ANTIHEMOPHILIC FACTOR/VON WILLEBRAND FACTOR COMPLEX
AryoGen Pharmed Co.
Phase 4BBB
Human-Cl Rhfviii
Octapharma
Phase 3BBB
Emicizumab
Chulalongkorn University
Phase 4BBB
Rfviiifc
Bioverativ Therapeutics Inc.
Phase 3BB
Frsw117
Hangzhou Gensciences Biopharmaceutical Co., Ltd.
Phase 3BB

View all 21 →

Same molecule, other indications

Alphanate Sd/Ht is also rated in:

von Willebrand disease (hereditary or acquired)Dormant
BB
Indicative ·
65 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →